{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:23:29Z","timestamp":1782221009948,"version":"3.54.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["NIDDK 1R01DK134347-01"],"award-info":[{"award-number":["NIDDK 1R01DK134347-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1R21HD104176-01"],"award-info":[{"award-number":["1R21HD104176-01"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.kint.2023.02.017","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T09:03:52Z","timestamp":1681895032000},"page":"839-841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The case for treatment of monogenic SRNS with calcineurin inhibitors"],"prefix":"10.1016","volume":"103","author":[{"given":"Brandon M.","family":"Lane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheed A.","family":"Gbadegesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2023.02.017_bib1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome","volume":"35","author":"Trautmann","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2023.02.017_bib2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1053\/j.ajkd.2008.11.033","article-title":"Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial","volume":"53","author":"Choudhry","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.02.017_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2215\/CJN.07370715","article-title":"Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome","volume":"11","author":"Buscher","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.02.017_bib4","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1681\/ASN.2016101121","article-title":"Long-term outcome of steroid-resistant nephrotic syndrome in children","volume":"28","author":"Trautmann","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.02.017_bib5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00467-020-04695-0","article-title":"Calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene mutations: a systematic review","volume":"36","author":"Malakasioti","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2023.02.017_bib6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.kint.2023.02.022","article-title":"A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants","author":"Malakasioti","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.02.017_bib7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2023.02.017_bib8","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/me.2011-0029","article-title":"Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in\u00a0vitro and in\u00a0vivo","volume":"25","author":"Wang","year":"2011","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.kint.2023.02.017_bib9","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1681\/ASN.2020081234","article-title":"A\u00a0rare autosomal dominant variant in regulator of calcineurin type 1 (RCAN1) gene confers enhanced calcineurin activity and may cause FSGS","volume":"32","author":"Lane","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823001412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823001412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:53:17Z","timestamp":1715143997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253823001412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0085253823001412"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2023.02.017","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The case for treatment of monogenic SRNS with calcineurin inhibitors","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.02.022","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}